A Single-Center Validation of the Accuracy of a Photoplethysmography-Based Smartwatch for Screening Obstructive Sleep Apnea.

Yibing Chen, Weifang Wang, Yutao Guo, Hui Zhang, Yundai Chen, Lixin Xie
Author Information
  1. Yibing Chen: Department of Respiratory and Critical Care Medicine, Senior Department of Respiratory and Critical Care Medicine, The First Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  2. Weifang Wang: Department of Respiratory and Critical Care Medicine, Senior Department of Respiratory and Critical Care Medicine, The First Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  3. Yutao Guo: Senior Department of Cardiology, The Six Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  4. Hui Zhang: Senior Department of Cardiology, The Six Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  5. Yundai Chen: Senior Department of Cardiology, The Six Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  6. Lixin Xie: Senior Department of Respiratory and Critical Care Medicine, The Eighth Medical Center PLA General Hospital, Beijing, People's Republic of China.

Abstract

BACKGROUND: Obstructive sleep apnea (OSA), the most common upper-airway disease, is closely associated with the risk of cardiovascular diseases. However, the early screening of OSA is a main challenge, relying on polysomnography (PSG) or home sleep apnea test (HSAT) in hospitals. Photoplethysmography (PPG) has been developed as a novel technology for screening of OSA, while the validation of PPG-based smart devices is limited compared to that for PSG or HSAT devices.
OBJECTIVE: This study aimed to investigate the feasibility and validity of a PPG-based smartwatch in the screening of OSA.
METHODS: A total of 119 patients were recruited from the Chinese People's Liberty Army General Hospital (Beijing, China). Among them, 20 patients were assessed for a whole-night sleep study by a smartwatch and PSG simultaneously, as well as 82 cases by a smartwatch and HSAT simultaneously. Using PSG or HSAT as the "gold standard", we compared the accuracy, sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and positive likelihood ratio (+LR) or negative likelihood ratio (-LR) at three apnea hypopnea index (AHI) levels: AHI≥5, AHI≥15, and AHI≥30.
RESULTS: A total of 17/119 patients were excluded from the study due to the poor quality of PPG signals. Among the remaining cases, 83 patients were diagnosed with OSA. Compared to HSAT device, the accuracy, sensitivity, and specificity of the PPG-based smartwatch in predicting moderate-to-severe OSA patients (AHI≥15) were 87.9%, 89.7%, and 86.0%, respectively. Compared to PSG device, the accuracy, sensitivity, and specificity of the PPG-based smartwatch in predicting OSA in patients (AHI≥5) were 81.1%, 76.5%, and 100%, respectively.
CONCLUSION: The PPG-based smartwatch outperformed in terms of detecting OSA; nevertheless, validation in a large-scale population is imperative.
TRIAL REGISTRATION: Chinese Clinical Trial Registry of the International Clinical Trials Registry Platform of the World Health Organization ChiCTR-OOC-17014138; http://www.chictr.org.cn/showprojen.aspx?proj=24191.

Keywords

References

  1. Sensors (Basel). 2020 Jan 04;20(1): [PMID: 31947905]
  2. IEEE Trans Biomed Eng. 2012 Feb;59(2):303-6 [PMID: 21803676]
  3. Medicine (Baltimore). 2017 May;96(18):e6755 [PMID: 28471970]
  4. Sleep Breath. 2014 May;18(2):375-82 [PMID: 24072550]
  5. J Sleep Res. 2012 Feb;21(1):94-100 [PMID: 21672069]
  6. J Clin Sleep Med. 2017 Mar 15;13(3):479-504 [PMID: 28162150]
  7. Lancet. 2009 Jan 3;373(9657):82-93 [PMID: 19101028]
  8. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:4844-7 [PMID: 19963862]
  9. Sleep Sci. 2019 Jul-Sep;12(3):214-221 [PMID: 31890098]
  10. Sleep. 2017 Jul 1;40(7): [PMID: 28838130]
  11. IEEE Trans Biomed Eng. 2009 Apr;56(4):1005-14 [PMID: 19272873]
  12. Sci Rep. 2020 Aug 11;10(1):13512 [PMID: 32782313]
  13. J Clin Monit Comput. 2019 Apr;33(2):341-345 [PMID: 29749570]
  14. J Clin Sleep Med. 2014 Mar 15;10(3):285-90 [PMID: 24634626]
  15. Lancet Respir Med. 2019 Aug;7(8):687-698 [PMID: 31300334]
  16. Eur J Anaesthesiol. 2011 Jan;28(1):34-8 [PMID: 20962650]
  17. Sleep Breath. 2013 Sep;17(3):1109-15 [PMID: 23386370]
  18. Healthc Technol Lett. 2016 Jun 13;3(2):136-42 [PMID: 27382483]
  19. Front Med (Lausanne). 2017 Mar 08;4:26 [PMID: 28337439]
  20. Zhonghua Yi Xue Za Zhi. 2016 May 24;96(19):1527-9 [PMID: 27266501]
  21. J Clin Monit Comput. 2006 Feb;20(1):33-6 [PMID: 16532280]
  22. J Healthc Eng. 2018 Jan 10;2018:1902176 [PMID: 29599944]
  23. Nat Rev Cardiol. 2019 Apr;16(4):203-212 [PMID: 30467329]
  24. J Clin Sleep Med. 2007 Dec 15;3(7):737-47 [PMID: 18198809]
  25. PLoS One. 2019 Jan 9;14(1):e0210569 [PMID: 30625225]

Word Cloud

Created with Highcharts 10.0.0OSAsleepsmartwatchpatientsapneaPSGHSATPPG-basedscreeningstudyaccuracysensitivityspecificityObstructivepolysomnographyhometestPPGvalidationdevicescomparedtotalChineseAmongsimultaneouslycasesnegativepredictivevaluepositivelikelihoodratioAHI≥5AHI≥15CompareddevicepredictingrespectivelyClinicalRegistryBACKGROUND:commonupper-airwaydiseasecloselyassociatedriskcardiovasculardiseasesHoweverearlymainchallengerelyinghospitalsPhotoplethysmographydevelopednoveltechnologysmartlimitedOBJECTIVE:aimedinvestigatefeasibilityvalidityMETHODS:119recruitedPeople'sLibertyArmyGeneralHospitalBeijingChina20assessedwhole-nightwell82Using"goldstandard"NPVPPV+LR-LRthreehypopneaindexAHIlevels:AHI≥30RESULTS:17/119excludedduepoorqualitysignalsremaining83diagnosedmoderate-to-severe879%897%860%811%765%100%CONCLUSION:outperformedtermsdetectingneverthelesslarge-scalepopulationimperativeTRIALREGISTRATION:TrialInternationalTrialsPlatformWorldHealthOrganizationChiCTR-OOC-17014138http://wwwchictrorgcn/showprojenaspx?proj=24191Single-CenterValidationAccuracyPhotoplethysmography-BasedSmartwatchScreeningSleepApneaobstructivephotoplethysmographypulseoximeter

Similar Articles

Cited By